Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Deficiency, Antibody”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03051425
What this trial is testing

Immune Benefits of Consumption of Dairy Yogurt in Elderly

Who this might be right for
Immune Deficiency
Yonsei University 200
Early research (Phase 1)Study completedNCT02658968
What this trial is testing

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Who this might be right for
Relapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Nordic Nanovector 18
Not applicableNot Yet RecruitingNCT07189013
What this trial is testing

Assessing Patient Preference for Infusion Systems

Who this might be right for
Primary Immunodeficiencies (PID)Secondary Immunodeficiencies (SID)
KORU Medical Systems, Inc. 52
Early research (Phase 1)Study completedNCT00001125
What this trial is testing

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

Who this might be right for
HIV InfectionsChickenpox
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04565015
What this trial is testing

Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Who this might be right for
Primary Immune Deficiency
GC Biopharma Corp 24
Testing effectiveness (Phase 2)Looking for participantsNCT06976476
What this trial is testing

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Who this might be right for
Multiple MyelomaHypogammaglobulinemiaHypogammaglobulinemia, Acquired
Memorial Sloan Kettering Cancer Center 100
Large-scale testing (Phase 3)Study completedNCT00000135
What this trial is testing

Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)

Who this might be right for
HIV InfectionsCytomegalovirus Retinitis
Johns Hopkins Bloomberg School of Public Health 209
Testing effectiveness (Phase 2)Study completedNCT02568215
What this trial is testing

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,924
Not applicableLooking for participantsNCT06716450
What this trial is testing

Multiplo Tp/HIV Self-Test

Who this might be right for
HIV InfectionSyphilis Infection
Unity Health Toronto 900
Testing effectiveness (Phase 2)Study completedNCT03721510
What this trial is testing

A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV/AIDS
International AIDS Vaccine Initiative 19
Not applicableStudy completedNCT02043379
What this trial is testing

Post-bypass Prophylactic IVIG in Infants and Neonates

Who this might be right for
HypogammaglobulinemiaCongenital Heart Disease
University of Alabama at Birmingham 50
Post-approval studies (Phase 4)Ended earlyNCT00023504
What this trial is testing

Antibody Production in Immune Disorders

Who this might be right for
Primary Immune Deficiency
National Institute of Allergy and Infectious Diseases (NIAID) 21
Testing effectiveness (Phase 2)Study completedNCT03366142
What this trial is testing

Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology

Who this might be right for
LAD1
National Institute of Allergy and Infectious Diseases (NIAID) 6
Early research (Phase 1)Study completedNCT00000642
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT00002286
What this trial is testing

Retrovir in the Treatment of Psoriasis in HIV-Positive Patients

Who this might be right for
HIV InfectionsPsoriasis
Glaxo Wellcome
Large-scale testing (Phase 3)Looking for participantsNCT07648264
What this trial is testing

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Who this might be right for
Secondary Immune Deficiency
CSL Behring 63
Not applicableStudy completedNCT00001999
What this trial is testing

A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
American National Red Cross
Not applicableStudy completedNCT03054181
What this trial is testing

Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)

Who this might be right for
Primary ImmunodeficiencySecondary Immune Deficiency
GWT-TUD GmbH 156
Early research (Phase 1)UnknownNCT00062530
What this trial is testing

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 38
Large-scale testing (Phase 3)Looking for participantsNCT06980480
What this trial is testing

Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaSecondary Immunodeficiency
Takeda 183
Next Page